Company profile: Inbrain Neuroelectronics
1.1 - Company Overview
Company description
- Provider of graphene-based brain-computer interface therapeutics and precision neurology solutions that combine high-resolution, skin-like BCI decoding with micrometric modulation in a closed loop to deliver adaptive, personalized treatments for Parkinsonβs disease, epilepsy, and stroke. Offerings include implantable neural processors, an AI-powered therapy platform, and Innervia systems for vagus nerve modulation.
Products and services
- Graphene-Based Neurotechnology: Flexible, implantable graphene assemblies deliver high-resolution, high-precision neural treatments through micrometric modulation and decoding, addressing Parkinsonβs disease, epilepsy, and stroke patients
- Brain-Computer Interfaces (BCI): Skin-like, bi-directional, high-resolution interfaces enable real-time smart neural decoding and modulation in a closed loop for precision neurology applications
- AI-Powered Platform: AI-driven system lets patients and clinicians personalize therapy using their own data to improve patient outcomes through adaptive treatment optimization
Key contacts
π
π
Financial details
π
1.2 - Competitors and similar companies to Inbrain Neuroelectronics
Liftware
HQ: United States
Website
- Description: Provider of electronic stabilizing and leveling utensil handles with interchangeable attachments (soup spoon, everyday spoon, fork, spork), designed to help people eat more easily by reducing utensil shaking for hand tremor and keeping utensils level for limited hand or arm mobility.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Liftware company profile β
Rapport Therapeutics
HQ: United States
Website
- Description: Provider of precision medicines for neurological disorders, leveraging a RAP Technology Platform to discover and develop small-molecule therapies targeting specific neuronal receptor complexes. Programs include TARPΞ³8 AMPAR small molecules in clinical development for epilepsy with potential in pain and bipolar disorder, and discovery-stage nAChR modulators for chronic pain and hearing disorders.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Rapport Therapeutics company profile β
Wesana Health
HQ: United States
Website
- Description: Provider of advancement of psilocybin-based medicine as a life sciences company.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Wesana Health company profile β
PaxMedica
HQ: United States
Website
- Description: Provider of biopharmaceutical therapies addressing neurodevelopmental disorders, including PAX-101 for early-stage East African Human African Trypanosomiasis and PAX-101 under development for Autism Spectrum Disorder. Conducts clinical trials evaluating suramin in ASD and collaborates on translational research to support research leading to FDA-approved treatments for autism comorbidities.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full PaxMedica company profile β
Keros Therapeutics
HQ: United States
Website
- Description: Provider of clinical-stage biopharmaceutical discovery, development, and commercialization of novel treatments.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Keros Therapeutics company profile β
π
2.M&A buyers
2.1 Potential strategic acquirers in the sector
π
π
π
π
View all strategic buyers with complete profiles
Start Free Trial β
2.2 - Strategic buyer groups for Inbrain Neuroelectronics
π
Buyer group 1: ββββββββ ββββββββ
ββ companies
Description: ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ
Key Products: ββββββββ, ββββββββ, ββββββββ, ββββββββ
π
View all companies in this group
Request Free Trial Now β
π
Buyer group 2: ββββββββ ββββββββ
ββ companies
Description: ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ
Key Products: ββββββββ, ββββββββ, ββββββββ, ββββββββ
π
View all companies in this group
Request Free Trial Now β
π
Buyer group 3: ββββββββ ββββββββ
ββ companies
Description: ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ
Key Products: ββββββββ, ββββββββ, ββββββββ, ββββββββ
π
View all companies in this group
Request Free Trial Now β
π Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial β
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Inbrain Neuroelectronics
2.2 - Growth funds investing in similar companies to Inbrain Neuroelectronics
π
View all growth equity funds with complete profiles
Start Free Trial β
4 - Top valuation comps for Inbrain Neuroelectronics
4.2 - Public trading comparable groups for Inbrain Neuroelectronics
π Unlock all public trading comparable groups with complete valuation data
Start Free Trial β